The concept of privileged structures in rational drug design: focus on acridine and quinoline scaffolds in neurodegenerative and protozoan diseases

Author： Bongarzone Salvatore   Bolognesi Maria Laura  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.6, Iss.3, 2011-03, pp. : 251-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Privileged Structures: A Useful Concept for the Rational Design of New Lead Drug Candidates

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1108-1119

Bentham Science Publishers

Access to resources Recommend Favorite

Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 19, 2016-08 ,pp. : 2201-2222

Bentham Science Publishers

Access to resources Recommend Favorite

Progresses in the Field of Drug Design to Combat Tropical Protozoan Parasitic Diseases

By  

Current Medicinal Chemistry, Vol. 13, Iss. 3, 2006-02 ,pp. : 335-360

Bentham Science Publishers

Access to resources Recommend Favorite

Quinoline as a Privileged Scaffold in Cancer Drug Discovery

By  

Current Medicinal Chemistry, Vol. 18, Iss. 10, 2011-04 ,pp. : 1488-1508

Bentham Science Publishers

Access to resources Recommend Favorite

Indole Alkaloids and Semisynthetic Indole Derivatives as Multifunctional Scaffolds Aiming the Inhibition of Enzymes Related to Neurodegenerative Diseases – A Focus on Psychotria L. Genus

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 8, 2014-01 ,pp. : 1056-1075

Bentham Science Publishers

Access to resources Recommend Favorite